Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: A mechanism involving the p38 MAP kinase and phosphorylation of ATF-2

Oncology Research

Volumn 15, Issue 3, 2005, Pages 113-128

  Lewis, Joan S ^a,c   Vijayanathan, Veena ^a   Thomas, T J ^a   Pestell, Richard G ^b   Albanese, Chris ^b   Gallo, Michael A ^a   Thomas, Thresia ^a,d  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d Division of Internal Medicine   (United States)

Author keywords

ATF 2; Cyclin D1; Estradiol; MCF 7 cells; Polyamines

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 2; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIN D1; ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SPERMINE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BREAST CANCER; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 22144449634     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504005776367924     Document Type: Article

References (64)

1. Hui, R.; Finney, G. L.; Carroll, J. S.; Lee, C. S.; Musgrove, E. A.; Sutherland, R. L. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogen in breast cancer cells. Cancer Res. 62: 6916-6923; 2002.
2. Castro-Rivera, E.; Samudio, I.; Safe, S. Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J. Biol. Chem. 276:30853-30861; 2001.
3. Thomas, T.; Gallo, M. A.; Thomas, T. J. Estrogen receptors as targets for drug development for breast cancer, osteoporosis and cardiovascular diseases. Curr. Cancer Drug Targets 4:483-499; 2004.
4. McKenna, N. J.; O'Malley, B. W. Minireview: Nuclear receptor coactivators-an update. Endocrinology 143:2461-2465; 2002.
5. Sabbah, M.; Courilleau, D.; Mester, J.; Redeuilh, G. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element. Proc. Natl. Acad. Sci. USA 96:11217-11222; 1999.
6. Henry, D. O.; Moskalenko, S. A.; Kaur, K. J.; Fu, M.; Pestell, R. G.; Camonis, J. H.; White, M. A. Ral GTPases contribute to regulation of cyclin D1 through activation of NF-κB. Mol. Cell. Biol. 20:8084-8092; 2000.
7. Pestell, R. G.; Albanese, C. M.; Reutens, A. T.; Segall, J. E.; Lee, R. J.; Arnold, A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr. Rev. 20:501-534; 1999.
8. Hai, T.; Liu, F.; Coukos, W.; Green, M. Transcription factor ATF cDNA clones: An extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 3:2083-2090; 1989.
9. Hai, T.; Curran, T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720-3724; 1991.
10. van Dam, H.; Duyndam, M.; Rottier, R.; Bosch, A.; de Vries Smits, L.; Herrlich, P.; Zantema, A.; Angel, P.; van der Eb, A. J. Heterodimer formation of c-Jun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12:479-484; 1993.
11. Tsai, E. Y.; Jain, J.; Pesavento, P. A.; Rao, A.; Goldfeld, A. E. Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFAT and ATF-2/JUN. Mol. Cell. Biol. 16:459-467; 1996.
12. Kim, S. J.; Wagner, S.; Liu, F.; O'Reilly, M. A.; Robbins, P. D.; Green, M. R. Retinoblastoma gene product activates expression of human TGF-2 beta 2 gene through transcription factor ATF-2. Nature 358:331-334; 1992.
13. Shimizu, M.; Nomura, Y.; Suzuki, H.; Ichikawa, E.; Takeuchi, A.; Suzuki, M.; Nakamura, T.; Nakajima, T.; Oda, K. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4. Exp. Cell Res. 239:93-103; 1998.
14. Beier, F.; Lee, R. J.; Taylor, A. C.; Pestell, R. G.; LuValle, P. Identification of the cyclin D1 gene as a target of activating transcription factor in chondrocytes. Proc. Natl. Acad. Sci. USA 96:1433-1438; 1999.
15. van Dam, H.; Castellazzi, M. Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene 20:453-2464; 2001.
16. Gupta, S.; Campbell, D.; Derijard, B.; Davis, R. J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393; 1995.
17. Livingstone, C.; Patel, G.; Jones, N. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14:1785-1797; 1995.
18. van Dam, H.; Wilhelm, D.; Herr, I.; Steffen, A.; Herrlich, P.; Angel, P. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14:1798-1811; 1995.
19. Thomas, T.; Trend, B.; Butterfield, J. R.; Janne, O. A.; Kiang, D. T. Regulation of ornithine decarboxylase gene expression in MCF-7 breast cancer cells by antiestrogens. Cancer Res. 49:5852-5857; 1989.
20. Manni, A. Polyamine involvement in breast cancer phenotype. In Vivo 16:493-500; 2002.
21. Tabor, C. W.; Tabor, H. Polyamines. Annu. Rev. Biochem. 53:749-790; 1984.
22. Thomas, T.; Thomas, T. J. Polyamines in cell growth and cell death: Molecular mechanisms and therapeutic applications. Cell. Mol. Life Sci. 58:244-258; 2001.
23. Canizares, F.; Salinas, J.; de las Heras, M.; Diaz, J.; Tovar, I.; Martinez, P.; Penafiel, R. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: Correlation with clinicopathologic parameters. Clin. Cancer Res. 5:2035-2041; 1999.
24. Manni, A.; Wechter, R.; Verderame, M. F.; Mauger, D. Cooperativity between the polyamine pathway and HER-2neu in transformation of human mammary epithelial cells in culture: Role of the MAPK pathway. Int. J. Cancer 76: 563-570; 1998.
25. Leroy, D.; Heriche, J. K.; Filhol, O.; Chambaz, E. M.; Cochet, C. Binding of polyamines to an autonomous domain of the regulatory subunit of protein kinase CK2 induces a conformational change in the holoenzyme. A proposed role for the kinase stimulation. J. Biol. Chem. 272: 20820-20827; 1997.
26. Kielosto, M.; Nummela, P.; Katainen, R.; Leaner, V.; Birrer, M. J.; Holtta, E. Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun. Cancer Res. 64:3772-3779; 2004.
27. Thomas, T.; Shah, N.; Klinge, C. M.; Faaland, C. A.; Adihkarakunnathu, S.; Gallo, M. A.; Thomas, T. J. Polyamine biosynthesis inhibitors alter protein-protein interactions involving estrogen receptor in MCF-7 breast cancer cells. J. Mol. Endocrinol. 22:131-139; 1999.
28. Maeda, Y.; Rachez, C.; Hawe, 3rd, L.; Byus, C. V.; Freedman, L. P.; Sladek, F. M. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein. Mol. Endocrinol. 16:1502-1510; 2002.
29. Celano, P.; Baylin, S. B.; Casero, Jr., R. A. Polyamines differentially modulate the transcription of growth-associated genes in human colon carcinoma cells. J. Biol. Chem. 264:8922-8927; 1989.
30. Pendeville, H.; Carpino, N.; Marine, J. C.; Takahashi, Y.; Muller, M.; Martial, J. A.; Cleveland, J. L. The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol. Cell. Biol. 21:6549-6558; 2001.
31. Yoshida, M.; Kashiwagi, K.; Shigemasa, A.; Taniguchi, S.; Yamamoto, K.; Makinoshima, H.; Ishihama, A.; Igarashi, K. A unifying model for the role of polyamines in bacterial cell growth: The polyamine modulon. J. Biol. Chem. 279:45737-45743; 2004.
32. Rhodes, D. R.; Barrette, T. R.; Rubin, M. A.; Ghosh, D.; Chinnaiyan, A. M. Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate. Cancer Res. 62:4427-4433; 2002.
33. Beier, F.; Ali, Z.; Mok, D.; Taylor, A. C.; Leask, T.; Albanese, C.; Pestell, R. G.; LuValle, P. TGFβ and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. Mol. Biol. Cell 12:3852-3863; 2001.
34. Albanese, C.; Wu, K.; D'Amico, M.; Attiga, F.; Joyce, D.; Hughes, J.; Hulit, J.; Sakamaki, T.; Fu, M.; Ben-Ze'ev, A.; Bromberg, J. F.; Lamberti, C.; Lin, K-M.; Gaynor, R. B.; Byers, S. W.; Pestell, R. G. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol. Biol. Cell 14:585-599; 2003.
35. Lee, R. J.; Albanese, C.; Stenger, R. J.; Watanabe, G.; Inghirami, G.; Haines, 3rd, G. K.; Webster, M.; Muller, W. J.; Brugge, J. S.; Davis, R. J.; Pestell, R. G. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. J. Biol. Chem. 274:7341-7350; 1999.
36. Shah, N.; Thomas, T. J.; Lewis, J. S.; Klinge, C. M.; Shirahata, A.; Gelinas, C.; Thomas, T. Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells. Oncogene 20:1715-1729; 2001.
37. Shah, N. N.; Thomas, T.; Shirahata, A.; Sigal, L. H.; Thomas, T. J. Activation of nuclear factor KB by polyamines in breast cancer cells. Biochemistry 38:14763-14774; 1999.
38. Liu, Y.; Asch, H.; Kulesz-Martin, M. F. Functional quantification of DNA-binding proteins p53 and estrogen receptor in cells and tumor tissues by DNA affinity immunoblotting. Cancer Res. 61:5402-5406; 2001.
39. Lewis, J. S.; Thomas, T. J.; Pestell, R. G.; Albanese, C.; Gallo, M. A.; Thomas, T. Differential effects of 16α-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells. J. Mol. Endocrinol. 34:91-105; 2005.
40. Maruvada, P.; Baumann, C. T.; Hager, G. L.; Yen, P. M. Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J. Biol. Chem. 278:12425-12432; 2003.
41. Klinge, C. M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 29:2905-2919; 2001.
42. Greenfield, N.; Vijayanathan, V.; Thomas, T. J.; Gallo, M. A.; Thomas, T. Increase in the stability and helical content of estrogen receptor alpha in the presence of the estrogen response element: Analysis by circular dichroism spectroscopy. Biochemistry 40:6646-6652; 2001.
43. Cocolakis, E.; Lemay, S.; Ali, S.; Lebrun, J. J. The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J. Biol. Chem. 276:18430-18436; 2001.
44. Bennett, B. L.; Sasaki, D. T.; Murray, B. W.; O'Leary, E. C.; Sakata, S. T.; Xu, W.; Leisten, J. C.; Motiwala, A.; Pierce, S.; Satoh, Y.; Bhagwat, S. S.; Manning, A. M.; Anderson, D. W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98: 13681-13686; 2001.
45. Alam, J.; Wicks, C.; Stewart, D.; Gong, P.; Touchard, C.; Otterbein, S.; Choi, A. M.; Burow, M. E.; Tou, J. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J. Biol. Chem. 275:27694-27702; 2000.
46. 5dC) and a plasmid containing the estrogen response element. J. Steroid Biochem. Mol. Biol. 54:89-99; 1995.
47. Panagiotidis, C. A.; Artandi, S.; Calame, K.; Silverstein, S. J. Polyamines alter sequence-specific DNA-protein interactions. Nucleic Acids Res. 23:1800-1809; 1995.
48. Kuramoto, N.; Inoue, K.; Gion, K.; Takano, K.; Sakata, K.; Ogita, K.; Yoneda, Y. Modulation of DNA binding of nuclear transcription factors with leucine-zipper motifs by particular endogenous polyamines in murine central and peripheral excitable tissues. Brain Res. 967:170-180; 2003.
49. Thomas, T.; Kulkarni, G. D.; Gallo, M. A.; Greenfield, N.; Lewis, J. S.; Shirahata, A.; Thomas, T. J. Effects of natural and synthetic polyamines on the conformation of an oligodeoxyribonucleotide with the estrogen response element. Nucleic Acids Res. 25:2396-2402; 1997.
50. Kousteni, S.; Bellido, T.; Plotkin, L. I.; O'Brien, C. A.; Bodenner, D. L.; Han, L.; Han, K.; DiGregorio, G. B.; Katzenellenbogen, J. A.; Katzenellenbogen, B. S.; Roberson, P. K.; Weinstein, R. S.; Jilka, R. L.; Manolagas, S. C. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell 104:719-730; 2001.
51. Migliaccio, A.; Di Domenico, M.; Castoria, G.; de Falco, A.; Bontempo, P.; Nola, E.; Auricchio, F. Tyrosine kinase/ p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1292-1300; 1996.
52. Kelly, M. J.; Levin, E. R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12: 152-156; 2001.
53. Song, R. X.-D.; McPherson, R. A.; Adam, L.; Bao, Y.; Shupnik, M.; Kumar, R.; Santen, R. J. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and She pathway activation. Mol. Endocrinol. 16: 116-127; 2002.
54. Filardo, E. J.; Quinn, J. A.; Frackelton, Jr., A. R.; Bland, K. I. Estrogen action via the G protein-coupled receptor, GPR30: Stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 16:7084; 2002.
55. Castoria, G.; Migliaccio, A.; Bilancio, A.; Di Domenico, M.; de Falco, A.; Lombardi, M.; Fiorentino, R.; Varricchio, L.; Barone, M. V.; Auricchio, F. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J. 20:6050-6059; 2001.
56. Madrid, L. V.; Mayo, M. W.; Reuther, J. Y.; Baldwin, Jr., A. S. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem. 276:18934-18940; 2001.
57. Yamaguchi, T.; Chattopadhyay, N.; Kifor, O.; Sanders, J. L.; Brown, E. M. Activation of p42/44 and p38 mitogen-activated protein kinases by extracellular calcium-sensing receptor agonists induces mitogenic responses in the mouse osteoblastic MC3T3-E1 cell line. Biochem. Biophys. Res. Commun. 279:363-368; 2000.
58. Chen, Y.; Alm, K.; Vujcic, S.; Kramer, D. L.; Kee, K.; Diegelman, P.; Porter, C. W. The role of mitogen-activated protein kinase activation in determining cellular outcomes in polyamine analogue-treated human melanoma cells. Cancer Res. 63:3619-3625; 2003.
59. Watanabe, S.; Kusama-Eguchi, K.; Kobayashi, H.; Igarashi, K. Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J. Biol. Chem. 266:20803-20809; 1991.
60. Pera, P. J.; Kramer, D. L.; Sufrin, J. R.; Porter, C. W. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. Cancer Res. 46:1148-1154; 1986.
61. Diehl, J. A. Cycling to cancer with cyclin D1. Cancer Biol. Ther. 1:226-231; 2002.
62. Lewis, J. S.; Thomas, T. J.; Klinge, C. M.; Gallo, M. A.; Thomas, T. Regulation of cell cycle and cyclins by 16α-hydroxyestrone in MCF-7 breast cancer cells. J. Mol. Endocrinol. 27:293-307; 2001.
63. Thomas, T.; Thomas, T. J. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: Therapeutic implications. Breast Cancer Res. Treat. 29:189-201; 1994.
64. Qin, C.; Samudio, I.; Ngwenya, S.; Safe, S. Estrogen-dependent regulation of ornithine decarboxylase in breast cancer cells through activation of nongenomic cAMP-dependent pathways. Mol. Carcinog. 40:160-170; 2004.